UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
 
For the month of, June 2018
Commission File Number 001-37652
 
Midatech Pharma PLC
(Translation of registrant’s name into English)
 
65 Innovation Drive
Milton Park
Abingdon, Oxfordshire, OX14 4RQ, United Kingdom
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
Form 20-F              Form 40-F 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): 
 

 

 
SUBMITTED HEREWITH
 
Attached to the Registrant’s Form 6-K filing for the month of June 2018, and incorporated by reference herein, is:
     
Exhibit No.
  
Description
   
99.1
 
Press release, dated June 1, 2018 entitled “2017 Annual Report and AGM Notification.”
     
99.2
  
Press release, dated June 1, 2018 entitled “Board Change.”
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
                 
 
 
 
 
Midatech Pharma PLC
       
Date: June 1, 2018
 
 
 
By:
 
/s/ Nicholas Robbins-Cherry
 
 
 
 
 
 
 
 
 
Nicholas Robbins-Cherry
Chief Financial Officer

 


Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Midatech Pharma Charts.
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Midatech Pharma Charts.